Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives $28.86 Consensus Target Price from Brokerages
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) has been assigned an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that have updated their coverage on the […]